Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/156043
Writers, readers and erasers of RNA modifications in cancer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Although cancer was originally considered a disease driven only by genetic mutations, it has now been proven that it is also an epigenetic disease driven by DNA hypermethylation-associated silencing of tumor suppressor genes and aberrant histone modifications. Very recently, a third component has emerged: the so-called epitranscriptome understood as the chemical modifications of RNA that regulate and alter the activity of RNA molecules. In this regard, the study of genetic and epigenetic disruption of the RNA-modifying proteins is gaining momentum in advancing our understanding of cancer biology. Furthermore, the development of epitranscriptomic anticancer drugs could lead to new promising and unexpected therapeutic strategies for oncology in the coming years.
Matèries
Matèries (anglès)
Citació
Citació
ESTEVE-PUIG, Rosaura, BUENO COSTA, Alberto, ESTELLER, Manel. Writers, readers and erasers of RNA modifications in cancer. _Cancer Letters_. 2020. Vol. 474, núm. 127-137. [consulta: 8 de abril de 2026]. ISSN: 0304-3835. [Disponible a: https://hdl.handle.net/2445/156043]